Trade Desk, Inc. (TTD) Insider Transactions
Explore official ownership filings, with every record linked to its source.
TTD · Trade Desk, Inc.
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-10-19Filed 2026-10-21 | Green Jeffrey TerryDirector · Officer · Ten-percent owner · President and CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This option was previously reported as covering 21,572 shares at an exercise price of $748.98 per share but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F2 The option is fully vested and exercisable. F3 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F6 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F3, F6 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 737,028A | — | Direct | Form 4 ↗0001671445-26-000012 |
| 2026-10-19Filed 2026-10-21 | Green Jeffrey TerryDirector · Officer · Ten-percent owner · President and CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This option was previously reported as covering 21,572 shares at an exercise price of $748.98 per share but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F2 The option is fully vested and exercisable. F3 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F6 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F3, F6 | D Other reported codeEmployee Stock Option (Right to Buy) · Derivative | 737,028D | — | Direct | Form 4 ↗0001671445-26-000012 |
| 2026-10-19Filed 2026-10-21 | Green Jeffrey TerryDirector · Officer · Ten-percent owner · President and CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This option was previously reported as covering 21,572 shares at an exercise price of $748.98 per share but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F2 The option is fully vested and exercisable. F3 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F6 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F3, F5 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 450,045A | — | Direct | Form 4 ↗0001671445-26-000012 |
| 2026-10-19Filed 2026-10-21 | Green Jeffrey TerryDirector · Officer · Ten-percent owner · President and CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This option was previously reported as covering 21,572 shares at an exercise price of $748.98 per share but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F2 The option is fully vested and exercisable. F3 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F6 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F3, F5 | D Other reported codeEmployee Stock Option (Right to Buy) · Derivative | 450,045D | — | Direct | Form 4 ↗0001671445-26-000012 |
| 2026-10-19Filed 2026-10-21 | Green Jeffrey TerryDirector · Officer · Ten-percent owner · President and CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This option was previously reported as covering 21,572 shares at an exercise price of $748.98 per share but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F2 The option is fully vested and exercisable. F3 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F6 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F3, F4 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 215,696A | — | Direct | Form 4 ↗0001671445-26-000012 |
| 2026-10-19Filed 2026-10-21 | Green Jeffrey TerryDirector · Officer · Ten-percent owner · President and CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This option was previously reported as covering 21,572 shares at an exercise price of $748.98 per share but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F2 The option is fully vested and exercisable. F3 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F6 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F3, F4 | D Other reported codeEmployee Stock Option (Right to Buy) · Derivative | 215,696D | — | Direct | Form 4 ↗0001671445-26-000012 |
| 2026-10-19Filed 2026-10-21 | Green Jeffrey TerryDirector · Officer · Ten-percent owner · President and CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This option was previously reported as covering 21,572 shares at an exercise price of $748.98 per share but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F2 The option is fully vested and exercisable. F3 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F6 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F3, F2 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 215,720A | — | Direct | Form 4 ↗0001671445-26-000012 |
| 2026-10-19Filed 2026-10-21 | Green Jeffrey TerryDirector · Officer · Ten-percent owner · President and CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This option was previously reported as covering 21,572 shares at an exercise price of $748.98 per share but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F2 The option is fully vested and exercisable. F3 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F6 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F1, F3, F2 | D Other reported codeEmployee Stock Option (Right to Buy) · Derivative | 215,720D | — | Direct | Form 4 ↗0001671445-26-000012 |
| 2026-10-19Filed 2026-10-21 | Olmstead NathanOfficer · Chief Financial OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option was granted on July 9, 2026, the Vesting Commencement Date ("VCD"). One-fourth (1/4th) of the shares subject to the option vest on the first anniversary of the VCD, with one forty-eighth (1/48th) of the shares subject to the option vesting on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced Options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. References: F2, F1 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 439,753A | — | Direct | Form 4 ↗0001776828-26-000012 |
| 2026-10-19Filed 2026-10-21 | Olmstead NathanOfficer · Chief Financial OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option was granted on July 9, 2026, the Vesting Commencement Date ("VCD"). One-fourth (1/4th) of the shares subject to the option vest on the first anniversary of the VCD, with one forty-eighth (1/48th) of the shares subject to the option vesting on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced Options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. References: F2, F1 | D Other reported codeEmployee Stock Option (Right to Buy) · Derivative | 439,753D | — | Direct | Form 4 ↗0001776828-26-000012 |
| 2026-10-19Filed 2026-10-21 | GRANT JAY ROfficer · Chief Legal OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option is fully vested and exercisable. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 This amount represents the Incentive Stock Option (ISO) portion of the grant on April 26, 2022, that was not eligible to participate in the Option Repricing. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 This amount represents the ISO portion of the grant on April 24, 2023, that was not eligible to participate in the Option Repricing. F6 The option was granted on April 23, 2024, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F7 This amount represents the ISO portion of the grant on April 23, 2024, that was not eligible to participate in the Option Repricing. F8 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F9 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F9 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 309,551A | — | Direct | Form 4 ↗0001826731-26-000012 |
| 2026-10-19Filed 2026-10-21 | GRANT JAY ROfficer · Chief Legal OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option is fully vested and exercisable. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 This amount represents the Incentive Stock Option (ISO) portion of the grant on April 26, 2022, that was not eligible to participate in the Option Repricing. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 This amount represents the ISO portion of the grant on April 24, 2023, that was not eligible to participate in the Option Repricing. F6 The option was granted on April 23, 2024, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F7 This amount represents the ISO portion of the grant on April 23, 2024, that was not eligible to participate in the Option Repricing. F8 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F9 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F9 | D Other reported codeEmployee Stock Option (Right to Buy) · Derivative | 309,551D | — | Direct | Form 4 ↗0001826731-26-000012 |
| 2026-10-19Filed 2026-10-21 | GRANT JAY ROfficer · Chief Legal OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option is fully vested and exercisable. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 This amount represents the Incentive Stock Option (ISO) portion of the grant on April 26, 2022, that was not eligible to participate in the Option Repricing. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 This amount represents the ISO portion of the grant on April 24, 2023, that was not eligible to participate in the Option Repricing. F6 The option was granted on April 23, 2024, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F7 This amount represents the ISO portion of the grant on April 23, 2024, that was not eligible to participate in the Option Repricing. F8 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F9 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F8 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 157,515A | — | Direct | Form 4 ↗0001826731-26-000012 |
| 2026-10-19Filed 2026-10-21 | GRANT JAY ROfficer · Chief Legal OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option is fully vested and exercisable. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 This amount represents the Incentive Stock Option (ISO) portion of the grant on April 26, 2022, that was not eligible to participate in the Option Repricing. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 This amount represents the ISO portion of the grant on April 24, 2023, that was not eligible to participate in the Option Repricing. F6 The option was granted on April 23, 2024, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F7 This amount represents the ISO portion of the grant on April 23, 2024, that was not eligible to participate in the Option Repricing. F8 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F9 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F8 | D Other reported codeEmployee Stock Option (Right to Buy) · Derivative | 157,515D | — | Direct | Form 4 ↗0001826731-26-000012 |
| 2026-10-19Filed 2026-10-21 | GRANT JAY ROfficer · Chief Legal OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option is fully vested and exercisable. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 This amount represents the Incentive Stock Option (ISO) portion of the grant on April 26, 2022, that was not eligible to participate in the Option Repricing. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 This amount represents the ISO portion of the grant on April 24, 2023, that was not eligible to participate in the Option Repricing. F6 The option was granted on April 23, 2024, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F7 This amount represents the ISO portion of the grant on April 23, 2024, that was not eligible to participate in the Option Repricing. F8 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F9 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F6 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 120,451A | — | Direct | Form 4 ↗0001826731-26-000012 |
| 2026-10-19Filed 2026-10-21 | GRANT JAY ROfficer · Chief Legal OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option is fully vested and exercisable. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 This amount represents the Incentive Stock Option (ISO) portion of the grant on April 26, 2022, that was not eligible to participate in the Option Repricing. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 This amount represents the ISO portion of the grant on April 24, 2023, that was not eligible to participate in the Option Repricing. F6 The option was granted on April 23, 2024, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F7 This amount represents the ISO portion of the grant on April 23, 2024, that was not eligible to participate in the Option Repricing. F8 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F9 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F6, F7 | D Other reported codeEmployee Stock Option (Right to Buy) · Derivative | 120,451D | — | Direct | Form 4 ↗0001826731-26-000012 |
| 2026-10-19Filed 2026-10-21 | GRANT JAY ROfficer · Chief Legal OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option is fully vested and exercisable. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 This amount represents the Incentive Stock Option (ISO) portion of the grant on April 26, 2022, that was not eligible to participate in the Option Repricing. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 This amount represents the ISO portion of the grant on April 24, 2023, that was not eligible to participate in the Option Repricing. F6 The option was granted on April 23, 2024, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F7 This amount represents the ISO portion of the grant on April 23, 2024, that was not eligible to participate in the Option Repricing. F8 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F9 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F4 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 55,317A | — | Direct | Form 4 ↗0001826731-26-000012 |
| 2026-10-19Filed 2026-10-21 | GRANT JAY ROfficer · Chief Legal OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option is fully vested and exercisable. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 This amount represents the Incentive Stock Option (ISO) portion of the grant on April 26, 2022, that was not eligible to participate in the Option Repricing. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 This amount represents the ISO portion of the grant on April 24, 2023, that was not eligible to participate in the Option Repricing. F6 The option was granted on April 23, 2024, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F7 This amount represents the ISO portion of the grant on April 23, 2024, that was not eligible to participate in the Option Repricing. F8 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F9 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F4, F5 | D Other reported codeEmployee Stock Option (Right to Buy) · Derivative | 55,317D | — | Direct | Form 4 ↗0001826731-26-000012 |
| 2026-10-19Filed 2026-10-21 | GRANT JAY ROfficer · Chief Legal OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option is fully vested and exercisable. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 This amount represents the Incentive Stock Option (ISO) portion of the grant on April 26, 2022, that was not eligible to participate in the Option Repricing. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 This amount represents the ISO portion of the grant on April 24, 2023, that was not eligible to participate in the Option Repricing. F6 The option was granted on April 23, 2024, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F7 This amount represents the ISO portion of the grant on April 23, 2024, that was not eligible to participate in the Option Repricing. F8 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F9 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F1 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 15,512A | — | Direct | Form 4 ↗0001826731-26-000012 |
| 2026-10-19Filed 2026-10-21 | GRANT JAY ROfficer · Chief Legal OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option is fully vested and exercisable. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 This amount represents the Incentive Stock Option (ISO) portion of the grant on April 26, 2022, that was not eligible to participate in the Option Repricing. F4 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 This amount represents the ISO portion of the grant on April 24, 2023, that was not eligible to participate in the Option Repricing. F6 The option was granted on April 23, 2024, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F7 This amount represents the ISO portion of the grant on April 23, 2024, that was not eligible to participate in the Option Repricing. F8 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F9 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F1, F3 | D Other reported codeEmployee Stock Option (Right to Buy) · Derivative | 15,512D | — | Direct | Form 4 ↗0001826731-26-000012 |
| 2026-10-19Filed 2026-10-21 | Kundra VivekOfficer · Chief Operating OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option was granted on April 3, 2025. The Vesting Commencement Date ("VCD") is March 31, 2025. One-fourth (1/4th) of the shares subject to the option vest on the first anniversary of the VCD, with one forty-eighth (1/48th) of the shares subject to the original grant vesting on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced Options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F3 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 309,551A | — | Direct | Form 4 ↗0001867888-26-000010 |
| 2026-10-19Filed 2026-10-21 | Kundra VivekOfficer · Chief Operating OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option was granted on April 3, 2025. The Vesting Commencement Date ("VCD") is March 31, 2025. One-fourth (1/4th) of the shares subject to the option vest on the first anniversary of the VCD, with one forty-eighth (1/48th) of the shares subject to the original grant vesting on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced Options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F3 | D Other reported codeEmployee Stock Option (Right to Buy) · Derivative | 309,551D | — | Direct | Form 4 ↗0001867888-26-000010 |
| 2026-10-19Filed 2026-10-21 | Kundra VivekOfficer · Chief Operating OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option was granted on April 3, 2025. The Vesting Commencement Date ("VCD") is March 31, 2025. One-fourth (1/4th) of the shares subject to the option vest on the first anniversary of the VCD, with one forty-eighth (1/48th) of the shares subject to the original grant vesting on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced Options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F1 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 160,792A | — | Direct | Form 4 ↗0001867888-26-000010 |
| 2026-10-19Filed 2026-10-21 | Kundra VivekOfficer · Chief Operating OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option was granted on April 3, 2025. The Vesting Commencement Date ("VCD") is March 31, 2025. One-fourth (1/4th) of the shares subject to the option vest on the first anniversary of the VCD, with one forty-eighth (1/48th) of the shares subject to the original grant vesting on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced Options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F1 | D Other reported codeEmployee Stock Option (Right to Buy) · Derivative | 160,792D | — | Direct | Form 4 ↗0001867888-26-000010 |
| 2026-10-19Filed 2026-10-21 | Davis Tahnil R.Officer · Chief Accounting Officer & EVPFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option is fully vested and exercisable. F2 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause. F3 The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F4 The option was granted on April 23, 2024, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F5 The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. F6 The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. References: F2, F6 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 309,551A | — | Direct | Form 4 ↗0002109272-26-000012 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.